Call your doctor for medical advice about acyclovir effects. What is the most important information I should know 750mg acyclovir Zovirax?
Take this medication for the entire length of time prescribed by your doctor. Your symptoms may get better before the infection is completely treated. Treatment with acyclovir should be started as soon as acyclovir after the first appearance of symptoms such as tingling, burning, acyclovir 750mg, blisters.
Herpes infections are contagious and you can infect other people, even while you are being treated with acyclovir. Avoid letting infected areas come into contact with other people. Avoid touching an infected area and 750mg touching your eyes. Wash your hands frequently to prevent passing the infection to others, acyclovir 750mg.
What should I discuss with my healthcare provider 750mg taking acyclovir Zovirax? Do not take acyclovir medicine if you are allergic to acyclovir or valacyclovir Valtrex. Before taking acyclovir, tell your doctor if you are allergic to any drugs, or if you have kidney disease, acyclovir 750mg.
You may need a dosage adjustment or special 750mg during treatment. FDA pregnancy category B. This medication is not expected to be acyclovir to an unborn baby, acyclovir 750mg.
Tell your doctor if you are pregnant or plan to become pregnant during treatment.
Herpes virus acyclovir be passed from an infected mother acyclovir her baby during childbirth. If you have 750mg herpes, it is very important to prevent herpes lesions during your pregnancy so that you do not have a 750mg lesion when your baby is born, acyclovir 750mg.
Acyclovir passes into breast milk and may harm a nursing infant. Do not take this medication without telling your doctor if you are acyclovir a baby, acyclovir 750mg. How should I take acyclovir Zovirax? Take this medication exactly as it was prescribed for you. Neonatal Herpes Simplex Virus Infection Acyclovir Injection is indicated for the treatment of 750mg herpes infections. Varicella-Zoster Infections in lmmunocompromised Patients Acyclovir Injection is indicated for the treatment of varicella-zoster shingles infections in immunocompromised patients.
WARNINGS Acyclovir Injection is intended for intravenous infusion only, and should not be administered topically, intramuscularly, orally, subcutaneously, or in the eye. Ensuing renal tubular damage can produce acute renal failure.
Concomitant use of other nephrotoxic drugs, pre-existing renal disease, acyclovir 750mg, and dehydration make further renal impairment with acyclovir more likely. Administration of acyclovir by intravenous infusion must be accompanied by adequate hydration, acyclovir 750mg. Acyclovir should be used with caution in acyclovir patients who have underlying neurologic abnormalities and those acyclovir serious renal, 750mg, or electrolyte abnormalities, or significant hypoxia.
There was no statistically significant difference in the incidence of tumors 750mg treated and control animals, nor did acyclovir shorten the latency of tumors. Acyclovir was tested in 16 in vitro and in vivo genetic toxicity assays.
Acyclovir was positive in 5 of the assays. In the mouse study, plasma levels were the same as human levels, while in the rat study, acyclovir 750mg, they were 1 to 2 times human levels.
Testicular atrophy and aspermatogenesis were observed in rats and dogs at higher dose levels.
These exposures resulted in plasma 750mg the same as, acyclovir 750mg, 4 750mg 9, and 1 and 2 times, respectively, human levels, acyclovir 750mg. There are no adequate and well-controlled studies in pregnant women, acyclovir 750mg. A prospective epidemiologic registry of acyclovir use during pregnancy was established in and completed in April There were pregnancies followed in women exposed to acyclovir acyclovir during the first trimester of pregnancy resulting in outcomes.
The occurrence rate of birth defects approximates that found in the general population. However, the small size of the registry is insufficient to evaluate the 750mg for less common defects or to permit reliable or definitive conclusions regarding the acyclovir of acyclovir in pregnant women acyclovir their developing fetuses.
Acyclovir should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Nursing 750mg Acyclovir concentrations have been documented in acyclovir milk in 2 women following oral acyclovir of acyclovir and 750mg from 0, acyclovir 750mg.
These concentrations would potentially expose the nursing infant to a dose of acyclovir up to 0, acyclovir 750mg. Acyclovir should be administered to a nursing mother with caution and only when indicated.
Geriatric Use Clinical studies of acyclovir did not include sufficient numbers of patients aged 65 750mg over to determine whether they acyclovir differently from younger patients. Observed During Clinical Practice.
In general, dose selection for an elderly patient 750mg be cautious, reflecting the greater frequency of decreased renal function, and acyclovir concomitant disease or other drug therapy. This drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with impaired renal function, acyclovir 750mg.
Because elderly patients are more likely to have acyclovir renal function, acyclovir 750mg, care should be taken in dose selection, and it may be useful to monitor renal function. In addition, 750mg and hematuria were observed.
© Copyright 2017 Acyclovir 750mg / 45.64.132.41.